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Two types of functionally different lymphocytes may be distinguished in mice by 
virtue of their surface antigenic markers (reviewed in reference 1).  Thymus-depend- 
ent  (T) 1 cells do not  show  immunoglobulin  (Ig)  detectable by  immunofluorescence 
but bear the 0-isoantigen marker. Thymus-independent (B) cells have easily demon- 
strable  immunoglobulin  and  lack the  0-marker.  The  mechanism  of  interaction be- 
tween lymphocytes and  antigens is not clearly understood.  It is generally accepted 
that B cells interact with antigen through specific immunoglobulin surface receptors. 
In experiments where mouse  lymphocyte suspensions were exposed in vitro to [125I]- 
antigen of high specific activity, it was found that both T  and B  cells could be spe- 
cifically killed by the  corresponding antigen, pointing toward specific receptors on 
T  cells as well (2-4). This T  cell "suicide" could  be  prevented  by  pretreatment  of 
the cells with anti-K  chain serum  (2), but  tile nature of T  cell receptors is, however, 
still highly controversial (reviewed in references 5  7). 
[I25I]Antigen  binding to cells can also be visualized by autoradiography (reviewed 
in references 7 and 8), and it was found that part of the binding cells could be sup- 
pressed by treatment with anti-0 serum  and complement and represented thus pre- 
sumably T  cells (9).  The same observation was made  using  immunocytoadherance 
to detect binding cells (10  12). 
It appeared to us  that  the  combination of autoradiographic examination of 
[~2~I]antigen-binding cells with the detection, on the same cell, of Ig or 0-markers 
by immunofluorescence would provide a  powerful tool lo distinguish and study 
in a direct way specific T  and B  cells. The nature of the receptor on both types 
of cells was approached in two ways: (a) by using various anti-Ig antibodies to 
inhibit antigen binding; this approach has been used by others but without the 
simultaneous direct detection of T  or B  markers on  the binding cell (reviewed 
1 Abbreviations used in Ibis paper: ALS, antimouse  lymphocyte serum; anti L, rabbit anti- 
mouse L chain; anti #,  rabbit antimouse/z-chain; antirabbit Ig, sheep antirabbit immuno- 
globulin;  B  cells,  thymus independent  lymphocytes;  Fab-poly-anti-Ig, monovalent  Fab 
fragments of rabbit polyvalent antiinouse  immunoglohulin;  FCS, fetal calf  serum;  Ig, im- 
munoglobulin;  M SH, Maia  squinado hemocyanin;  NRS, normal  rabbit serum;  poly-anti-Ig, 
rabbit  polyvalent  antimouse  immunoglolmlin;  rhod-anti-0,  rhodamine-conjugated  anti-0 
immunoglobulin  G; T cells, thymus-dependent lymphocytes; TIGAL, heavily iodinated (Tyr, 
Glu)-Ala--Lys; TRITC, tetramethylrhodamine isothiocyanate. 
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in  references  5  and  11);  (b)  by  exploiting  the  recent  findings  on  lymphocyte 
membrane fluidity (13,  14). Cross-linking of surface immunoglobulins and other 
membrane-bound  antigens  induces  the  formation  of  microaggregates  (spots), 
which  migrate  in  the plane  of the  membrane  to form caps,  followed by  endo- 
cytosis.  Membrane  components  move independently  of each  other,  e.g.,  treat- 
ment of lymphocytes with anti-Ig sera induces Ig capping but leaves histocom- 
patibility  antigens  evenly  distributed  and  vice  versa.  Thus  the  capacity  of 
various antisera  to induce capping  of antigen  receptors  on T  cells would be in 
our opinion a good way to study the nature of these receptors. 
Materials and Methods 
Antisera--Antitheta C3H serum was obtained in AKR mice (15). Rhodamine-conjugated 
Ig anti-0  (rhod-anti-0)  was a gift of Dr.  F. Loor; the IgG fraction was isolated by agarose 
block  electrophoresis and  conjugated  with  tetramethylrhodamine  isothiocyanate  (TRITC) 
(Baltimore Biological Laboratories,  Baltimore,  Md.)  by the dialysis method  described  by 
Raft et al. (16). Specificity was ascertained by the absence of staining of AKR mouse thymo- 
cytes and nude mouse spleen cells  (20)<  106 cells in 0.2 ml plus 0.2 ml of rhod-anti-0 at  an 
Ig concentration of 0.5 mg/ml) as well as by the complete elimination of the capacity to stain 
C3H lymphocytes by absorption with C3H brain  (0.2 ml of rhod-anti-0 at an Ig concentra- 
tion of 0.5 mg/ml was absorbed with freshly homogenized brain from three mice). 
Antimouse lymphocyte serum was prepared by the method of Levey and Medawar (17). It 
had a  100% cytotoxic activity for thymocytes (5  X  106 cells in a final volume of 0.1 ml)  up 
to a dilution of 1:1,024. 
Polyvalent rabbit antimouse immunoglobulin antibody (poly-anti-Ig) and its monovalent 
Fab fragments (Fab-poly-anti-Ig) were prepared and characterized as described in (14). Poly- 
anti-Ig was conjugated with TRITC (18). Some rhod-poly-anti-Ig was absorbed twice with 5 
mg of unsolubilized mouse IgG myeloma protein per ml serum (RPC-23 IgG1; 5563 IgG2a; 
MOPC-141 IgG2b)  (19). These myeloma proteins were the generous gift of Dr. G. Torrigiani 
and  their preparation and  characterization have been described  (20).  After absorption, this 
serum no longer stained any spleen cells  (20  X  106 cells in 0.2  ml plus 0.2  ml of absorbed 
serum). 
Rabbit antimouse #-chain antiserum (anti-#) was a gift from Dr. G. Torrigiani; it was pre- 
pared  by injection of MOPC-104E  mouse IgM myeloma protein isolated from serum  (20). 
Absorption was performed with mouse IgG myeloma proteins  (RPC-23 IgG1; 5563 IgG2a; 
MOPC-141 IgG2b) made insoluble by cross-linking  with ethylchloroformate (19).  Mter ab- 
sorption the undiluted antiserum gave a single line in agarose immunodiffusion when reacted 
with undiluted normal mouse serum and did not react with mouse myeloma IgG of the dif- 
ferent subclasses  tested at a protein concentration of 5,1, and 0.1 mg/ml. In addition anti-# did 
not stain surface IgG1 immunoglobulins of P3 myeloma cells 2 (20 X  106 cells in 0.2 ml plus 
0.2 ml of anti-# at a concentration of 0.5 mg Ig/ml revealed with rhodamine-labeled antirabbit 
Ig), which could be stained by both specific anti-IgG1 and poly-anti-Ig. Anti-# did not ag- 
glutinate sheep red blood cells coated with purified mouse IgG when tested by the method 
of Gordon et al. (21). 
Rabbit antimouse light chain antiserum (anti-L) was a gift from Dr. G. Torrlgiani; it was 
prepared by injection of light chains obtained by reduction and alkylation of purified mouse 
serum IgG (22).  This anti-L, when revealed by rhodamine-labeled sheep  antirabbit  Ig, re- 
acted with the same number of spleen or lymph node cells as rhod-poly-anti-Ig. It had almost 
exclusively anti-K specificity (G. Torrigiani, personal communication). 
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Sheep antirabbit  immunoglobulin antiserum  (antirabbit Ig) was obtained by injection of 
rabbit Cohn fraction II  (Mann Research Labs., Inc., New York) and the Ig fraction was con- 
jugated with TRITC  (18). It was used to localize unlabeled anti-# or anti-L bound on  cells 
by a  sandwich technique (14), under which conditions it did not stain mouse spleen cells di- 
rectly. 
Although none of these anti-immunoglobulin reagents stained mouse thymus cells even at 
an Ig concentration of 2.5 mg/ml, they were nevertheless absorbed with thymocytes (8 X  10  s 
cells/ml for 12 h  at 4°C). 
Antigens.--Maia squinado hemocyanin (MSH) and heavily iodinated (Tyr, Glu)-Ala--Lys 
synthetic polypeptide (TIGAL)  type 52  (50 atoms of I/molecule)  were  12aI radioiodinated 
by the chloramine-T method  (3,  9).  Specific activity ranged from 150  to 300 #Ci/#g.  MSH 
seems to be completely thymus dependent  (23)  but only the 7S response of TIGAL  52  (J. 
Humphrey and N. Willcox, personal communication). 
Animals.  C3H/He and (A/J)< CBA/J)F1 mice, 3-6 mo old, were used unprimed or after 
a  single intraperitoneal injection of 100  #g  of alum-precipitated antigen  (MSH  or TIGAL 
iodinated with nonradioactive iodine) with 109 killed Bordetella pertussis organisms. 
Double Labeling of Cells with [t25I]Antigen and Rhodamine Antibody.--Spleen  cell suspen- 
sions were filtered in ice through cotton gauze to remove clumps, washed twice in Hanks' 
balanced salt solution, and resuspended at a concentration of l0  s cells/ml in the appropriate 
medium (see below). 
Conditions for spot and cap formation on lymphocytes, as well as their inhibition, has been 
described in detail (13,  14).  Unless specifically indicated, "noncapping conditions" were used, 
thus keeping the cells close to 0°C, suspended in 3% bovine serum albumin phosphate-buffered 
saline, 1.5 mM NAN3, or, for exposure to [125I]antigen,  medium 199 with 10% fetal calf serum 
(FCS) and 1.5 mM NAN3. 
Exposure of cells to [12SI]antigen was as described (9). Briefly, 20  X  106 cells were mixed 
with 1 #g of [125I]antigen in a total volume of 0.4 ml, maintained on ice for 1 h,  spun, resus- 
pended in 0.5 ml, passed through an FCS gradient, and washed once more. The cells resus- 
pended in 0.1 ml were then incubated with 0.2 ml rhod-poly-anti-Ig, anti-# or anti-L (0.5 mg 
Ig/ml), or rhod-anti-0 (0.2 mg Ig/ml) for 30 rain on ice and washed three times. Rhod-anti- 
rabbit Ig was used to reveal binding of anti-# or anti-L. 
Inhibition  of Antigen  Binding  by Anti-Immunoglobulin  Antibody.  Cells were incubated 
with normal rabbit serum  (NRS),  rhod-poly-anti-Ig, anti-#, anti-L (all at 2.5 mg Ig/ml), or 
Ig-absorbed rhod-poly-anti-Ig for 30 min in the cold, washed three times, and exposed to the 
radio]abeled antigen. 
Anti-# and anti-L antibodies fixed on the cell membranes were detected by staining with 
rhod-anti-rabbit-Ig after  exposure to  antigen.  Inhibition  of antigen  binding was  also tried 
using antimouse lymphocyte serum  (ALS)  at a  final dilution of 1:100  at which all lympho- 
cytes were very brightly stained with the same ALS conjugated with rhodamine and which 
did not induce redistribution of surface markers under the usual capping conditions. 
Redistribution of Antigen Receptors by Anti-Immunoglobulin  Antibody.  To induce capping 
of immunoglobulin  receptors,  the  cells were  incubated  with  rhod-poly-anti-Ig, anti-#,  and 
anti-L  (all at 0.5  mg Ig/ml)  for 30 min in the cold in  199  medium with  10%  FCS without 
NaN3, washed three times with the same medium, and put at 37°C for 10 rain. The cells were 
then centrifuged, resuspended in NaN3 containing medium to stop the capping process, and 
exposed to [l~:'I]antigen under noncapping conditions. The cells treated with unlabeled anti-L 
were stained with rhod-antirabbit Ig after exposure to antigen, and the cells treated with un- 
labeled anti-# were stained with either rhod-antirabbit Ig or rhod-poly-anti-Ig. 
Staining  with rhod-anti-O in Inhibition  and Receptor Redistribution Experiments.--Prelim- 
inary experiments showed that cells that had fixed poly-anti-Ig or anti-L would take up rhod- 
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rhod-anti-0, they could be used in conjunction with anti-# antibody in both inhibition and 
capping experiments. Moreover Dr. F. Loot (personal communication) has shown that mono- 
valent Fab-poly-anti-Ig bound to B  cells and cross-linked with a second layer of sheep anti- 
rabbit Ig did not pick up rhod-anti-~. Thus rhod-anti-0 was also used after capping induction 
with Fab-poly-anti-Ig and antirabbit Ig. 
Redistribution of Antigen.--The cells were incubated with [125I]MSH for 1 h at 37°C in 199 
medium (10% FCS without azide). Incubation with radioactive antigen was also carried out 
in conditions described to produce a large number of human T  rosettes to sheep erythrocytes 
(24),  that is 5 rain at 37°C followed by 1 h at 0°C in medium containing 1.2  mM  Ca  ++  and 
1.0 mM Mg  ++. As control, cells were preincubated for 5 rain at 37°C before addition of antigen. 
The cells were then studied for Ig or 0 under noncapping conditions. 
Autoradlography and Microscopy.--Cells were smeared on slides subbed in 0.1%  gelatin 
and 0.01% chrome alum, fixed for 5 rain in absolute ethanol at room temperature, processed 
for autoradiography using Ilford K5 emulsion (Ilford Ltd., Ilford, Essex, England), and de- 
veloped 2-4 days later (9). The slides were observed under phase contrast at 1,000 magnifica- 
tion with Leitz Orthoplan microscopes equipped with Osram HBO-200 mercury vapor lamps 
and Opak-Fluor vertical illuminators (E. Leitz, Wetzlar, West Germany) (25).  Each antigen- 
binding cell (20 grains above the background, which in most experiments was negligible) was 
observed under selective illumination for the visualization of rhodamine (25). To avoid scoring 
false negatives,  the  antigen-binding cells apparently negative for  surface immunoglobulin 
were systematically photographed on Kodak TRI-X PAN 23 DIN black-white film (Eastman 
Kodak Co., Rochester, N. Y.) using 4-min exposure times. 
RESULTS 
Antigen-Binding  B  and  T  Lymphocytes.--Spleen  cells of mice primed with 
TIGAL or MSH were exposed to the appropriate radioactive antigen, washed, 
and incubated with either rhod-poly-anti-Ig or rhod-anti-8. All the steps were 
carried out on ice in the presence of azide,  thus under noncapping conditions. 
Examination of labeled cells showed that there was no significant interference 
between  the  silver grains  and  the fluorescence and  that cells could be easily 
scanned for one and the other (see Figs. 1-4). There was no correlation between 
the number of grains and the brightness of the fluorescence either by Ig or 8. 
In all instances antigen grains and Ig or 8-fluorescence were evenly distributed 
and never in caps. 
Since we want to focus on the comparison of B  and T  binding cells rather 
than on their precise quantification,  and  since  results obtained with TIGAL 
and MSH were identical in this respect, they were pooled together in Table I, 
which represents the mean of 14 concordant experiments. 
Primed  cells  taken  1-2  mo  after priming  contained  more  antigen-binding 
cells (0.38%) than 3.5-4 mo after priming (0.07 %). The anti-Ig or anti-8 treat- 
ment subsequent to antigen binding did not influence the number of binding 
cells detected.  1-2-too primed cells showed a  ratio of Ig+  to Ig--  and 8--  to 
8+  antigen-binding cells of about 4:1 that dropped to about 2:1 for 3.5--4-mo 
primed  cells.  Although  the  overall  scoring  seems  to  indicate  a  possible  8% 
overlap between 8+ and Ig+ antigen-binding cells (22 % 8+ cells but only 14 % 
Ig--, 1-2 mo after priming), when the same cell suspension was stained for Ig 1064  T  AND  B  LYMPHOCYTE RECEPTORS 
Antigen-binding cells.  (a)  Cells  unstained in  phase contrast.  X  1,000. (b)  Same field in 
fluorescence selected for rhodamine. 
FIG.  1. An Ig+ antigen-binding cell. 
FIG. 2. An Ig-- antigen-binding cell. 
FIG. 3. A 0+ antigen-binding cell. 
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and 0,  the number of Ig+  and 0--  or Ig--  and 0+  antigen-binding cells were 
practically identical. Furthermore,  in inhibition and capping experiments pre- 
sented below, the results were identical whether Ig+  or 0-- cells were examined 
or Ig-  and  8+  cells. Thus,  although  some  overlap cannot  be  excluded,  the 
bulk of Ig+ and 0--  antigen-binding cells may be considered as B  lymphocytes 
and the bulk of Ig- and 8+  antigen-binding cells as T  lymphocytes. Antigen- 
binding cells of both types can be easily distinguished and studied separately. 
Table II shows that within the range we were able to quantitate  (60-1,200 
molecules per cell), the degree of labeling of B  and T  cells was identical. This 
is  in  contradiction  with  the  conclusions  reached  from  experiments  in  which 
indirect evaluation of T  antigen-binding cells was done by killing with anti-0 
serum and complement (9). Since cells with more than  1,200 molecules started 
to show confluent grains, it was not possible to determine in a quantitative way 
if the parallel between T  and B  cells was also valid for the most heavily labeled 
cells. All we can say is that very heavily labeled T  cells do exist (see Figs. 1-4). 
The  frequency  of  antigen-binding  cells  in  unprimed  spleens  was  roughly 
0.01%. Heavily antigen-labeled T  cells (Ig- or 8+) were seen, but not enough 
cells were counted to give a valid quantification. 
TABLE I 
B  and  T  Antigen-Binding  Cells in  Primed  Spleens 
no. of cells 
counted 
Antigen-binding  B  cells  T  ceils 
cells* 
no.  %  of total  no.  %  of total  no.  %  of total 
1-2mo after  35,471  134  0.38  Ig+  115  86  Ig--  19  14 
priming  44,855  171  0.38  O--  134  78  O+  37  22 
Total  80,326  305  0.38  249  82  56  18 
3.54 mo after  98,789  75  0.07  Ig+  52  69  Ig--  23  31 
priming  20,075  14  0.07  O--  11  79  O+  3  21 
Total  118,864  89  0.07  63  71  26  29 
* Cells binding more than 60 molecules of antigen. 
TABLE II 
Degree of Labeling  of T  and  B  Cells Exposed  to Radioactive  Antigen* 
no. of antigen  molecules per cell 
60-299  300-599  600-1,199  > 1,200 
%  %  %  % 
Ig+ or O--  9  22  28  41 
Ig-- or O+  5  23  30  42 
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Inhibition  of Antigen Binding by Anti-Immunoglobulin  Antibody.--To try to 
inhibit antigen binding, the cells were incubated with rhod-poly-anti-Ig, anti-#, 
and anti-L at an Ig concentration of 2.5 mg/ml before exposure to [l~SI]antigen. 
The specific anti-# and anti-L sera were prepared by absorption and also ab- 
sorbed with thymocytes. No unspecific antimembrane activity could be demon- 
strated  (see Materials and Methods).  Ig+  cells were detected by the directly 
conjugated rhod-poly-anti-Ig or by adding, after exposure to [l~SI]antigen, rhod- 
antirabbit  Ig to cells incubated  with  anti-L.  #+  cells were  also  detected  by 
adding, after exposure to [125I]antigen, rhod-antirabbit Ig to cells incubated with 
anti-#. 
It was found in preliminary experiments that anti-0 antibody, being itself of 
mouse origin, was picked up by cells having bound poly-anti-Ig or anti-L anti- 
bodies. However, since only IgG fractions had been used to make rhod-anti-0 
antibody,  it could be used  to stain  the  cells where inhibition  had  been  tried 
with anti-/z. 
The  inhibition  of antigen  binding  was  calculated  by comparison  with  the 
number of antigen-positive cells found in the same cell suspension by treatment 
with [125I]antigen followed by rhod-poly-anti-Ig. Normal rabbit serum with an 
Ig  concentration  approximately  identical  with  that  of  the  various  anti-Ig 
preparations served as control. Even when not absorbed with cells it did not 
inhibit antigen binding. 
The results are shown in Table III. For antigen-binding B cells,  poly-anti-Ig 
inhibited  78%  and  anti-L  91%.  After  treatment  with  anti-#  the  cells  were 
stained with either rhod-poly-anti-Ig detecting all the Ig+  cells or rhod-anti- 
rabbit Ig detecting only the p+  cells. Anti-/~ inhibited 50 % of the Ig+  or 0- 
antigen-binding cells and 80% of the #+  antigen-binding cells. One should thus 
be careful here to distinguish inhibitory efficiency from reactivity. Higher con- 
centrations were not used to see if all the cells could be inhibited. Binding to T 
cells  was  practically  completely inhibited  by  poly-anti-Ig,  anti-L,  and  also 
TABLE  III 
Inhibition  of  Antigen Binding by  Anti-Immunoglobulin Antibody 
Antibody~: 
Inhibition of antigen-binding cells* 
Igq- or0--  Ig-- or O+ 
% 
Poly-anti-Ig§  78  (96  55) 
Anti-L  91 
Anti-pll  50  (66-33) 
NRS  No inhibition 
% 
>95 
>97 
>95 
No inhibition 
* Concordant results were obtained with TIGAL and MSH. 
:~ 2.5 mg Ig/mh 
§ Mean of three experiments. 
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anti-#. Preliminary experiments with more diluted antibody also showed 60 % 
inhibition of T  antigen-binding cells at concentrations giving only at most 10 % 
inhibition of B antigen-binding cells. Thus it appears that binding of antigen to 
T  cells is more readily inhibited by anti-immunoglobulin antibody than to B 
cells. The T  antigen-binding cells,  unlike B cells,  were completely inhibited by 
anfi-/z as well as anti-L,  suggesting that T  receptors for antigen  are IgM. In 
contrast to anti-Ig, ALS did not inhibit antigen binding by B or T cells (Table 
IV). 
In  some experiments,  cells were  exposed to  anti-0  before or  together with 
[125I]antigen. No inhibition of binding was observed. 
Redistribution of Antigen Receptors by A nti-Immunoglobulin A ntibody.--Capp- 
ing of the surface Ig of B lymphocytes can be induced by anti-Ig antibody and 
followed by fluorescence (13,  14).  It was argued that (a) if these Ig's were the 
TABLE  IV 
Inhibition of Antigen Binding by Antilymphocyte Serum* 
Control  ALS 
No. of cells counted  23,918  22,008 
No. of antigen-binding cells  95  87 
Total  0.40%  0.39% 
Ig+  80%  78% 
Ig--  20%  22% 
* Cells were incubated with ALS or NRS, washed, and  treated  with  [125I]TIGAL fol- 
lowed by rhod-poly-anti-Ig. 
receptors for [125I]antigen, the silver grains should be seen in caps superimposed 
on the Ig fluorescent caps; and  (b) if the receptors on T  cells were indeed im- 
munoglobulins, as suggested by the inhibition experiments, they would also be 
induced to cap by anti-Ig antibody. Consequently, on T  cells as on the B cells, 
the [125I]antigen grains would appear in caps. 
Capping  was  induced  by poly-anti-Ig,  anti-/z,  anti-L,  or  Fab-poly-anti-Ig 
combined with antirabbit Ig at an Ig concentration of 0.5 mg/ml that produced 
no discernible inhibition of antigen binding. The cells were then washed, brought 
to noncapping conditions,  exposed to [125I]antigen, and stained for the Ig or 0- 
markers (see Materials and Methods). 
Since cells do not cap synchronously after treatment with anti-Ig, some cells 
will already start endocytosis while others do not yet show an apparent redistri- 
bution.  In  order not  to  score false  Ig or  antigen-negative  cells,  capping was 
stopped after 10 rain, at which time no significant endocytosis had yet occurred. 
Thus all stages of Ig or antigen redistribution could be seen from complete con- 
centration on one pole of the cell to still apparently even distribution over the 
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than half of the cell, and antigen when there was a markedly asymmetrical con- 
centration of the grains. Due to scattering, a complete absence of grains on half 
of the cells was not always obtained  (see Figs.  1-4). 
The results were similar with the various combinations of reagents used  and 
are presented  together in Table V. 83 % of the Ig+ cells had coincident antigen 
grains and Ig fluorescence, 57 %  had superimposed caps; 26 %  were still evenly 
distributed;  15 %  had the Ig fluorescence in cap but not the antigen,  probably 
indicating still incomplete capping of the Ig receptors on those cells. Four cells 
were found with the antigen in cap but not the Ig. Of crucial significance, antigen 
was detected in caps on 54% of the T  cells (Ig- or 0+), a proportion very close 
to that found for B  cells. 
TABLE V 
Anti-Immunoglobulln-Indueed Redistribution of Antigen Receptors on B and T Calls* 
Antigen-binding cells  no. of cells 
Antigen  Immunoglobulin 
no.  %  of total  exam ned 
Ig+ cells  Noncapping  Noncapping  89  26 
Capping:~  Capping~  195  57 
Noncapping  Capping  52  15 
Capping  Noncapping  4  1  307,000 
Ig- or  Noncapping  50  46 
0+ cells  Capping  59  54  345,000 
* Compiled from nine experiments using poly-anti-Ig, anti-/~, anti-L, or anti-Fab antibody 
under capping conditions followed by [I25I]antigen  and the appropriate  rhod-anti-Ig or rhod- 
anti-0  under noncapping  conditions.  Concordant  results  were obtained  with  TIGAL and 
MSH. 
Cells were scored as capped when they had Ig or antigen concentrated  in less than half 
of the cell surface. 
The antigen-capped 0+ cells still had the 0-fluorescence diffuse as usual, show- 
ing again the specificity of capping induction.  Significant capping was not in- 
duced in B or T  cells by treatment with NRS or Ig-absorbed rhod-poly-anti-Ig 
(Table VI). 
Since  capping  of  antigen  receptors  on  T  cells  was  induced  by  four  well- 
characterized preparations as different as poly-anti-Ig, anti-~, anti-L, and Fab- 
poly-anti-Ig that had all been extensively absorbed with thymocytes, and since 
significant capping was not induced by NRS or Ig-absorbed poly-anti-Ig, it is 
extremely improbable that all the antisera would contain antibodies against a T 
receptor that would not be immunoglobulin but be absorbable by Ig prepara- 
tions.  Since in addition the rate of capping was identical in T  and B  cells,  one 
is forced to conclude that by far the most likely explanation is that the T  recep- 
tors for TIGAL and MSH are immunoglobulin. 
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TABLE VI 
Specificity of Anti-Immunoglobulin-Induced Redistribution of Antigen Receptors  on B  and  T 
Cells* 
Antigen  Immunoglobulin 
Antigen-bindlng cells~ 
rhod-poly-  Normal rabbit  Ig-absorbed  rhod-poly-  anti-Ig  serum  anti-Ig 
no.  %of total  no.  %of total  no.  %of total 
Ig+ cells  Noncapping  Noncapping  20  22  97  99  73  88 
Capping§  Capping§  64  71  0  0  3  4 
Noncapping  Capping  6  7  0  0  1  1 
Capping  Noncapping  0  0  1  1  61[  7 
Ig- cells  Noncapping  10  31  17  94  22  96 
Capping  22  69  1  6  1  4 
*  Rhod-poly-anti-Ig,  NRS,  or  Ig-absorbed  rhod-poly-anti-Ig  used  under capping  con- 
ditions followed by [i25I]TIGAL  and rhod-poly-anti-Ig  (for the last two groups) under non- 
capping conditions. 
:~ 60,000-70,000 cells were counted per group. 
§ Cells were scored as capped when they had Ig or antigen concentrated in less than half 
of the cell surface. 
[] Those six cells were all very low antigen binders (60-130 molecules). 
TABLE VII 
Redistribution of MSH on B  and T  Cells* 
Antigen  no. of antigen-binding  ceils  Decrease  antigen-binding  in no. of 
ceils vs. controls 
Ig+ or 0--  Noncapping  43  None 
Capping~  44 
Ig-- or 0+  Noncapping  3  69% 
Capping:~  2 
* [!25I]MSH under  capping  conditions  followed by  rhod-poly-anti-Ig  or  rhod-anti-0 
under noncapping conditions. 
:~ Cells were scored as capped when they had antigen concentrated in less than half of the 
cell surface. 
of receptors by antigen itself would cause capping on B and T  cells as well. Cells 
were exposed to [125I]MSH and kept for 1 h in capping conditions, washed, and 
incubated with either rhod-poly-anti-Ig  or rhod-anti-0 under noncapping condi- 
tions. The results are presented in Table VII. About 50% of the B cells had the 
antigen in caps, but all still had Ig distributed over the whole surface, indicating 
that the concentration of antigen used (2.5 #g/ml) was not saturating the recep- 
tors. There was no decrease in the number of B  antigen-binding  cells compared 1070  T  AND  B  LYMPHOCYTE  RECEPTORS 
with controls. On the contrary, only 31% of the expected T antigen-binding cells 
were found. 
Conditions described by Jondal et al. (24) to produce a large number of human 
T rosette-forming cells for sheep erythrocytes were also used to see if the number 
of T  or B binding cells or the capping pattern with antigen would be modified. 
Cells were incubated with [I~SI]MSH for 5 min at 37°C in 199 medium (1.2 mM 
Ca  ++,  1.0 mM Mg  ++,  10% FCS), cooled, and incubated further in ice for 1 h. 
Cells were also first incubated  5  rain  at 37°C  by themselves and the  antigen 
added when they were brought to 0°C. They were then stained with rhod-anti-0 
or rhod-poly-anti-Ig. These treatments had no influence on the number of bind- 
ing cells nor did  they induce  capping on either T  or B  cells.  The kinetics of 
capping of antigen on T  and B cells is being further investigated. 
DISCUSSION 
The main scope of our work was to establish the existence of antigen-binding 
T  lymphocytes and to collect information on the nature of antigen-binding re- 
ceptors on these cells. Our approach was based on the identification of each cell 
that had bound radioactive antigen as B or T  on the basis of its reactivity with 
fluorescent anti-0 or fluorescent anti-Ig. Our assumption was that a T cell would 
be identified by immunofluorescence as 0 positive or as immunoglobulin nega- 
tive, whereas the reverse would happen in the case of a B cell. This assumption is 
grounded on several previous observations (reviewed in reference 1) and is valid 
provided that some potential errors or limitations are duly taken into account, 
both with regard to the identification of T  on the basis of 0 positivity and of B 
on the basis of reactivity with anti-Ig serum. 
For the first kind of identification the main problem is the specificity of the 
anti-0 antiserum employed. When prepared in other than a congenic strain of 
mice, antibodies of unwanted specificity may be present, especially antiallotype 
antibodies (26), autoantibodies  (27),  and others (28). 
After conjugation  with  rhodamine,  the  isolated  IgG fraction  of the  anti-0 
serum did not stain AKR mouse thymocytes nor nude mouse spleen cells. More- 
over, its capacity to stain C3H thymocytes or spleen cells was completely re- 
moved by absorption with C3H brain (see Materials and Methods). Thus it ap- 
peared that, although not prepared in a congenic strain of mice, the rhod-anti-0 
stained only T  cells. 
On the other hand,  the identification  as  B  cells of cells positive in immuno- 
fluorescence with anti-immunoglobulin antisera is not only subject to the spe- 
cificity of the antisera employed, but is also in apparent contradiction with the 
statements of several workers (11,  29-33)  and even with the conclusion of our 
own work reported here, namely that there are immunoglobulins on the surface 
of the T  lymphocytes. What one can say in this respect is that these molecules 
are not easily demonstrable by immunofluorescence, and in fact, were not seen 
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The combined percentages of 0-1- and Ig-t- cells in a given sample were always 
very close to 100. In addition, throughout this work very similar results were 
obtained irrespective of whether T  cells were scored as 0-t-  or Ig-  and B cells 
as 0--  or Ig-l-. Therefore we are confident that we have indeed been studying 
the  antigen-binding  properties of  two  separate  populations  of mouse  spleen 
lymphocytes corresponding to the thymus-dependent (T) and to the thymus- 
independent (B) cells. They will therefore be discussed separately. 
Antigen-Binding B Lymphocytes.--With the two antigens used, the B antigen- 
binding cells were always more numerous than the T antigen-binding cells, about 
80% 1-2 mo after priming and about 70% 3-4 mo after priming; nevertheless, 
in none of our experiments were the B cells the only antigen-binding cells; there- 
fore, the conclusion of Warner (34) and Lamelin et al.  (35) that demonstrable 
[125I]antigen binding is  an  exclusive property of B  cells does not  seem to be 
generally valid. 
Under the conditions used, our attempt to quantitate the number of antigen 
molecules bound by individual B  lymphocytes could only resolve the low end 
of the spectrum, since beyond the level of approximately 1,200 molecules per 
cell,  the grains became confluent and could not be counted (Table II). Inter- 
estingly there was  no  correlation between  the  number  of antigen molecules 
bound by a given B cell and the intensity of the anti-immunoglobulin staining; 
thus it is possible that the affinity and not the number of the receptors could 
be  the  main  factor in determining  the variability in  the  number of antigen 
molecules bound by different B cells. 
When  capping  of  B  cell  immunoglobulins  was  induced  by  anti-immuno- 
globulin antibodies used at a concentration insufficient to inhibit antigen binding 
(0.5 mg Ig/ml), as a rule the antigen bound was detected at a site corresponding 
to the Ig (Table V). However, in a small but significant proportion of B  cells 
(15 %) this did not happen, and the result was that although immunoglobulins 
localized by immunofluorescence appeared to be in cap, the antigen molecules 
demonstrated by autoradiography were still apparently uniformly distributed 
around the cell. The reason for this unexpected finding is still not elucidated, 
but it might be that those were B cells with high affinity receptors (they were 
indeed all  in  the high  grain count range)  and that  in  thOse  cells incomplete 
capping of the surface immunoglobulins left behind a number of receptors in- 
sufficient to be detected by immunofluorescence but sufficient to bind antigen 
molecules, whereas  in  the  immunoglohulin cap  the  packing  of the  immuno- 
globulin-anti-immunoglobulin  complex did  not  allow  an  appreciably higher 
density of bound antigen molecules; thus the fluorescent Ig would appear as a 
cap while the antigen grains would not. 
It would not be surprising if for cells with high  affinity receptors and for 
antigens possessing many identical determinants, like those used, the antigen/ 
antibody ratio was different in a cap as compared with areas of the cell where 
receptors are more sparse. The demonstration by autoradiography of antigen 1072  T  AND  B  LYMPHOCYTE  RECEPTORS 
bound in areas of B cells where immunoglobulins are not demonstrable by im- 
munofluorescence underscores the difference in sensitivity of the two techniques 
and is an element to be remembered when discussing the nature of the antigen- 
binding receptors of T  cells. 
Good inhibition of antigen binding to B cells was obtained by pretreating the 
cells with a polyvalent antimouse Ig or an antimouse L  chain antiserum used 
at a concentration of 2.5 mg Ig/ml. On the other hand, only about one half of 
the antigen-binding B cells were inhibited by a comparable concentration of an 
antimouse #-antiserum. This discrepancy was presumably due to the presence 
in primed mice of an appreciable proportion of antigen-specific B lymphocytes 
with receptors of other immunoglobulin classes. 
Experiments in which MSH was allowed to redistribute in polar caps (Table 
VII) demonstrated that, at the concentration of antigen used,  the  B  binding 
sites were not saturated,  as evidence by the persistence of Ig fluorescence all 
around the cells. The same result was also obtained using polymerized flagellin 
by M.  Raft  (personal communication). However, he was also able to demon- 
strate that higher doses of the same antigen could completely carry along all the 
Ig in the antigen cap. 
Anligen-Binding  T  Lymphocyles.--Indirect  techniques  using  radioactive 
antigen have provided negative  (34,  35)  and  positive  (9,  36)  evidence for T 
antigen-specific binding cells.  By the  simultaneous double-labeling technique 
used here the existence of these cells was directly demonstrated confirming the 
results of T  cell suicide experiments (2-4). 
Lamelin et al. (35) also used labeling with [12~I]antigen and fluorescent antisera 
but did not detect antigen-binding T  cells.  This may be due to differences in 
techniques, mainly the use of antimouse thymocyte serum to identify T  cells 
and  of  sandwich  fluorescent  techniques  exclusively.  Antimouse  thymocyte 
serum is notoriously difficult to characterize, and its ability to detect all and 
only T  cells very controversial. Sandwich procedures with  some antisera,  in- 
eluding the  poly-anti-Ig used  in  the present  study,  have  in  our hands  been 
found to displace most of the bound antigen from the surface of the cell. We are 
studying further if this displacement is easier for T  cells. 
The absolute numbers of T  antigen-binding cells,  as well as their ratio to the 
number of B antigen-binding cells, were very similar for both antigens used, but 
this should not be generalized to all antigens and consequently one should not 
conclude that antigen-binding T  cells, as a group, are inferior in number to the 
antigen-binding B lymphocytes; in fact, ratios of T and B sheep red cell-binding 
b~nphocytes have been reported to fluctuate considerably during the course of 
immunization (12). 
The number of antigen molecules bound by each T  lymphocyte appears to 
vary within  a  wide range with  a  distribution  very similar to  that  of B  cells 
(Table  II);  by analogy with  B  lymphocytes it  seems  probable  that  affinity 
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number of antigen molecules bound per T  cell as well.  There is a considerable 
number of T cells that bind more than 1,200 molecules (Table II); therefore, in 
considering that both antigens employed had multiple identical antigenic de- 
terminants,  one may conclude that  there are T  cells that have a  number of 
antigen-binding receptors ranging in the order of thousands. Experiments are in 
progress to extend the comparative quantitative analysis of antigen bound by 
T  and B lymphocytes to cells that bind more than 1,200 molecules of antigen. 
Probably the most interesting part of this work concerns the effect of anti- 
immunoglobulin antibodies on antigen binding by T cells. There was practically 
complete inhibition of antigen binding on T  cells by pretreatment with anti- 
mouse immunoglobulin (polyvalent), antimouse L chain, and antimouse/~-chain 
(all 2.5 mg Ig/ml). Furthermore, when the lymphocytes were pretreated with 
subinhibiting  concentrations  of antimouse  immunoglobulin  antibodies  under 
conditions that induced about 50 % of the B cells to display superimposed Ig and 
antigen caps, a comparable proportion of T cells also bound the antigen as a cap 
(Table V). The latter effect was not obtained when the  antimouse immuno- 
globulin  antiserum was used  after absorption with  a  purified preparation of 
mouse immunoglobulin different from the preparation that had been employed 
to raise the  antiserum  (Table VI). Together with  the lack of any significant 
effect of normal rabbit serum, this supports the conclusion that the capping of 
receptors for antigen in our T  cells was induced through the specific effect of 
anti-immunoglobulin antibodies. 
In spite of the reassuring observation that the effect of anti-immunoglobulin 
antisera on T cell receptors for antigens was abolished by absorption of the anti- 
sera with purified immunoglobulins, the possibility was still considered that this 
might have been due to some other antibodies present in the antisera directed 
against nonimmunoglobulin components of the lymphocyte membrane. While 
this possibility is difficult to rule out completely, it is made unlikely by the fact 
that an antiserum rich in such antibodies  (an antilymphocyte antiserum that 
reacted strongly in direct immunofluorescence with the membranes of all mouse 
lymphocytes) did not significantly inhibit the antigen binding by either T  or B 
cells (Table IV). 
On the whole, our conclusion is that the antigen-binding moiety on the surface 
of a T  cell is immunoglobulin or a molecule closely associated in the membrane 
with immunoglobulin. It is clear that the former possibility, as in the case of B 
cells,  is by far the simplest and therefore the most likely one. In addition, the 
almost complete inhibition of antigen binding to T  cells by antiserum specific 
for mouse #-chains indicates that antigen-binding immunoglobulin molecules of 
T lymphocytes are probably IgM. Interestingly enough, no difference was found 
in antigen binding by T  (or B) cells when the cells were exposed to the antigen 
for 5 min at 37°C and then in the cold, instead of in the cold only. This observa- 
tion, which is not unexpected if the antigen-binding molecule is an immuno- 
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from events that require cell membrane mobility like those involved in the non- 
immune adhesion of sheep erythrocytes to human T  lymphocytes (24). On the 
other hand, when lymphocytes were exposed to MSH for 1 h at 37°C in absence 
of NaN~, T  and B cells behaved in a different way; the T  cells tended to lose 
the antigen much more quickly either by shedding of the receptor or by endocy- 
tosis followed by rapid digestion of antigen and elimination of the radioactive 
marker. We are now studying these events by observing the cells at intervals 
shorter than 1 h. 
Having reached the conclusion that antigen-binding molecules of T  lympho- 
cytes are immunoglobulins, it remains to be proved that  they are  the active 
products of the cells that carry them,  and are not passively acquired, for in- 
stance as cytophilic antibodies. The latter possibility is practically excluded by 
the very fact that antigen-binding cells were always a small minority of the total 
T cell population, but one might consider the possibility that antigen molecules 
bound in vivo or in vitro by nonimmunoglobulin T  receptors might be binding 
soluble antibodies and that these, in turn, might bind more radioactive antigen. 
This possibility is extremely unlikely if one considers the procedures employed 
in the binding and in the inhibition experiments, as well as the long period of 
time between  the injection in  the  animals  of antigens  that  are known  to be 
rapidly cleared in vivo and  the collection of the cells.  Therefore, through the 
functional tests used in this series of experiments, it can be concluded that the 
antigen-binding receptors of T  ]ymphocytes are immunoglobulins. 
This conclusion is in agreement with  the findings of others using immuno- 
cytoadherence (11),  electron microscopy  (29),  cytotoxicity (30),  or chemical 
approaches (31-33) to identify T cell receptors. Tbere are, however, important 
differences between the membrane-bound immunoglobulin receptors of T  and 
B cells in that the former bind much less anti-immunoglobulin antibodies than 
the latter. 
The fact that Ig was not detected by fluorescence even on heavily labeled 
antigen-binding cells or when the antigen was seen in cap remains largely unex- 
plained. It is well known that T cells bind much less anti-immunoglobulin than 
B  cells; thus it is not usually possible to visualize T  cell  membrane immuno- 
fluorescence by  staining  with  fluorochrome-conjugated anti-immunoglobulin 
antisera as used in our experiments (reviewed in reference 1). One factor may be 
that T cells have fewer Ig receptors than B cells, and that we were only detecting 
those of higher affinity; thus they would be closer to saturation and give de- 
tectable antigen binding by autoradiography but no detection by fluorescent 
anti-Ig.  On the other hand,  T  cell Ig receptors may have a  different kind of 
association with  the cell membrane rendering them less  accessible to anti-Ig 
sera (11, 29). 
Finally, we wish to point out that these experiments are concerned exclusively 
with the binding by T  and B  cells of soluble antigen molecules, but that cell 
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of T ceils the product(s) of Ir genes (37). Moreover, they do not exclude that for 
interaction with antigen on surfaces (such as membranes of other cells) the T 
lymphocyte may have ways and means of specific recognition that are different 
from, or possibly additional to, the immunoglobulin molecules. 
SUMMARY 
Antigen-binding  T  and  B  lymphocytes  were  studied  by  combined  auto- 
radiography and immunofluorescence; mouse spleen lymphocytes binding  the 
antigens,  [125I]MSH or  [125I]TIGAL,  were  incubated  with  rhodamine-labeled 
anti-Ig reagents or with  a  rhodamine-labeled IgG fraction of anti-0 serum. B 
cells were identified as Ig+ or 0--, T  cells as Ig-- or 0+. 
It was found that:  (a) 20%  (1-2 mo after priming) to 30%  (3.5-4 mo after 
priming)  of the  antigen-binding  cells were T  cells.  (b)  The  range  of antigen 
molecules bound by B and T  cells was similar. (c) Binding of antigen to B and 
T  cells was inhibited by pol~walent anti-Ig, anti-#, or anti-L reagents. Binding 
to T  cells was more readily inhibited  than  to B  cells.  Normal rabbit serum, 
antimouse  lymphocyte serum,  or  anti-0  did  not  inhibit  antigen  binding.  (d) 
When Ig at the surface of B cells was induced, by noninhibiting concentrations 
of anti-Ig reagents,  to redistribute  into polar caps and the cells subsequently 
exposed  to  [125I)antigen  under  noncapping  conditions,  the  [125I]antigen  silver 
grains were distributed in caps superimposed on the Ig fluorescent cap. Of cru- 
cial importance, antigen was found in cap in the same proportion of T cells as B 
cells.  Significant capping of antigen receptors was not induced in B  or T  cells 
with normal rabbit serum or by anti-Ig reagents absorbed with mouse Ig. 
The main conclusions of this series of experiments using direct visualization 
of antigen-binding B  and T  lymphocytes is that T  cells have antigen-specific 
receptors, probably of IgM nature, and that the number of these receptors ap- 
pears to range in the order of thousands. 
We are greatly indebted to Dr.  F. Loot for the conjugation of rhodamine-labeled anti-0 
immunoglobulins and to Dr. G. Torrigiani for the gift of various antimouse immunoglobulin 
preparations. We thank Dr. J. W. Goodman and Dr. J. R. Kettman for reviewing the manu- 
script and Miss A. Ryden for outstanding technical assistance. 
Noted Added  in  Proof.--Since  this  work was  accepted  for publication, we have 
studied the effect of decreasing  the concentration of [125I]antigen on the  labeling  of 
B and T  lymphocytes. At an antigen concentration similar  to that used by Lamelin 
et al.  (35), that is  100 times lower  than the one used  in this paper, the number of 
antigen-binding cells detected was about 10 times lower  and the degree  of labeling 
weak  (below 50 grains). Moreover only very rare T  binding cells were seen. Thus, 
there is no contradiction between the results reported here and those of Lamelin et al. 
(35). 
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